Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1980 2
1981 1
1982 1
1983 3
1984 3
1985 2
1986 2
1987 1
1988 2
1989 4
1990 6
1991 5
1992 3
1993 3
1994 12
1995 10
1996 8
1997 13
1998 19
1999 13
2000 20
2001 24
2002 25
2003 40
2004 32
2005 49
2006 80
2007 57
2008 92
2009 122
2010 141
2011 184
2012 215
2013 232
2014 264
2015 289
2016 285
2017 317
2018 357
2019 420
2020 506
2021 528
2022 637
2023 701
2024 803
2025 764
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,542 results

Results by year

Filters applied: . Clear all
Page 1
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
Ma L, Hu X, Song L, Chen X, Ouyang M, Billot L, Li Q, Malavera A, Li X, Muñoz-Venturelli P, de Silva A, Thang NH, Wahab KW, Pandian JD, Wasay M, Pontes-Neto OM, Abanto C, Arauz A, Shi H, Tang G, Zhu S, She X, Liu L, Sakamoto Y, You S, Han Q, Crutzen B, Cheung E, Li Y, Wang X, Chen C, Liu F, Zhao Y, Li H, Liu Y, Jiang Y, Chen L, Wu B, Liu M, Xu J, You C, Anderson CS; INTERACT3 Investigators. Ma L, et al. Lancet. 2023 Jul 1;402(10395):27-40. doi: 10.1016/S0140-6736(23)00806-1. Epub 2023 May 25. Lancet. 2023. PMID: 37245517 Free PMC article. Clinical Trial.
Genetically engineered pig-to-human liver xenotransplantation.
Zhang W, Xu Q, Xu K, Jiang R, Wang S, Zheng M, Liu N, Jiao D, Wang Z, Ge J, Lu X, Li G, Huang F, Liu L, Yin Y, Liu Y, Guo J, Liu K, Wei HJ, Sun B. Zhang W, et al. Among authors: jiang r. J Hepatol. 2025 Oct 9:S0168-8278(25)02497-3. doi: 10.1016/j.jhep.2025.08.044. Online ahead of print. J Hepatol. 2025. PMID: 41076089
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative.
Terry Fox Research Institute Marathon of Hope Cancer Centers Network. Electronic address: mmarra@bcgsc.ca; Terry Fox Research Institute Marathon of Hope Cancer Centers Network. Terry Fox Research Institute Marathon of Hope Cancer Centers Network. Electronic address: mmarra@bcgsc.ca, et al. Cancer Cell. 2025 Apr 14;43(4):587-592. doi: 10.1016/j.ccell.2025.03.014. Epub 2025 Apr 3. Cancer Cell. 2025. PMID: 40185094 Review.
Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Yang Z, Li Z, Zhan Y, Lin Z, Fang Z, Xu X, Lin L, Li H, Lin Z, Kang C, Liang J, Liang S, Li Y, Li S, Yang X, Ye F, Zhong N; Onradivir Trial Recruitment and Medical Monitoring Group. Yang Z, et al. Lancet Infect Dis. 2024 May;24(5):535-545. doi: 10.1016/S1473-3099(23)00743-0. Epub 2024 Feb 5. Lancet Infect Dis. 2024. PMID: 38330975 Clinical Trial.
Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial.
Galsky MD, van der Heijden MS, Powles T, Claps M, Burotto M, Schenker M, Sade JP, Bamias A, Beuzeboc P, Bedke J, Oldenburg J, Ürün Y, Ye D, Valderrama BP, Tomita Y, Jiang R, Filian J, Wang L, van Kooten Losio M, Sonpavde G. Galsky MD, et al. Among authors: jiang r. Eur Urol. 2025 Oct;88(4):325-330. doi: 10.1016/j.eururo.2025.04.019. Epub 2025 May 20. Eur Urol. 2025. PMID: 40393861 Free article. Clinical Trial.
Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial.
Liu Z, Wang D, Li G, Yi M, Zhang Z, Zhong G, Xu L, Jiang R, Zheng Y, Huang L, Peng Y, Liang L, Li J, Liu Y, Lai J, Lv X, Xu Y, Liu Q, Wang Z, Liu Z, Yang Q, Nie L, Lei J, Huang X, Liu Z, Jiang W. Liu Z, et al. Among authors: jiang r. Nat Commun. 2025 May 17;16(1):4608. doi: 10.1038/s41467-025-59865-1. Nat Commun. 2025. PMID: 40382318 Free PMC article. Clinical Trial.
6,542 results